Annual Working Capital
$360.31 M
+$96.12 M+36.38%
December 31, 2024
Summary
- As of March 10, 2025, AMPH annual working capital is $360.31 million, with the most recent change of +$96.12 million (+36.38%) on December 31, 2024.
- During the last 3 years, AMPH annual working capital has risen by +$146.00 million (+68.13%).
- AMPH annual working capital is now at all-time high.
Performance
AMPH Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$360.31 M
-$26.63 M-6.88%
December 31, 2024
Summary
- As of March 10, 2025, AMPH quarterly working capital is $360.31 million, with the most recent change of -$26.63 million (-6.88%) on December 31, 2024.
- Over the past year, AMPH quarterly working capital has stayed the same.
- AMPH quarterly working capital is now -6.88% below its all-time high of $386.94 million, reached on September 30, 2024.
Performance
AMPH Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
AMPH Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +36.4% | 0.0% |
| 3 y3 years | +68.1% | 0.0% |
| 5 y5 years | +118.1% | 0.0% |
AMPH Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +68.1% | -6.9% | +170.4% |
| 5 y | 5-year | at high | +118.1% | -6.9% | +170.4% |
| alltime | all time | at high | +241.2% | -6.9% | +337.5% |
Amphastar Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $360.31 M(+36.4%) | $360.31 M(-6.9%) |
| Sep 2024 | - | $386.94 M(+11.9%) |
| Jun 2024 | - | $345.67 M(+15.3%) |
| Mar 2024 | - | $299.91 M(+13.5%) |
| Dec 2023 | $264.19 M(-6.8%) | $264.19 M(-7.3%) |
| Sep 2023 | - | $285.04 M(+113.9%) |
| Jun 2023 | - | $133.27 M(-55.9%) |
| Mar 2023 | - | $302.04 M(+6.6%) |
| Dec 2022 | $283.46 M(+32.3%) | $283.46 M(+0.5%) |
| Sep 2022 | - | $282.03 M(+3.1%) |
| Jun 2022 | - | $273.51 M(+9.4%) |
| Mar 2022 | - | $250.05 M(+16.7%) |
| Dec 2021 | $214.31 M(+28.0%) | $214.31 M(+4.2%) |
| Sep 2021 | - | $205.68 M(+10.3%) |
| Jun 2021 | - | $186.42 M(+7.7%) |
| Mar 2021 | - | $173.07 M(+3.3%) |
| Dec 2020 | $167.48 M(+1.4%) | $167.48 M(-6.9%) |
| Sep 2020 | - | $179.82 M(+3.6%) |
| Jun 2020 | - | $173.53 M(+6.2%) |
| Mar 2020 | - | $163.35 M(-1.1%) |
| Dec 2019 | $165.23 M | $165.23 M(-9.4%) |
| Sep 2019 | - | $182.31 M(-0.5%) |
| Jun 2019 | - | $183.13 M(+55.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $118.18 M(+4.1%) |
| Dec 2018 | $113.51 M(-5.9%) | $113.51 M(+15.6%) |
| Sep 2018 | - | $98.18 M(+19.2%) |
| Jun 2018 | - | $82.36 M(-18.9%) |
| Mar 2018 | - | $101.50 M(-15.8%) |
| Dec 2017 | $120.59 M(-2.3%) | $120.59 M(+1.3%) |
| Sep 2017 | - | $119.09 M(-8.3%) |
| Jun 2017 | - | $129.88 M(+9.5%) |
| Mar 2017 | - | $118.56 M(-4.0%) |
| Dec 2016 | $123.48 M(+6.5%) | $123.48 M(-4.5%) |
| Sep 2016 | - | $129.35 M(+11.8%) |
| Jun 2016 | - | $115.65 M(+6.6%) |
| Mar 2016 | - | $108.52 M(-6.4%) |
| Dec 2015 | $115.98 M(-14.3%) | $115.98 M(-9.7%) |
| Sep 2015 | - | $128.41 M(-4.5%) |
| Jun 2015 | - | $134.49 M(+3.1%) |
| Mar 2015 | - | $130.51 M(-3.6%) |
| Dec 2014 | $135.40 M(+25.9%) | $135.40 M(-11.0%) |
| Sep 2014 | - | $152.10 M(-3.7%) |
| Jun 2014 | - | $157.94 M(+51.2%) |
| Mar 2014 | - | $104.48 M(-2.9%) |
| Dec 2013 | $107.57 M(+1.9%) | $107.57 M |
| Dec 2012 | $105.61 M | - |
FAQ
- What is Amphastar Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual working capital year-on-year change?
- What is Amphastar Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly working capital year-on-year change?
What is Amphastar Pharmaceuticals annual working capital?
The current annual working capital of AMPH is $360.31 M
What is the all time high annual working capital for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual working capital is $360.31 M
What is Amphastar Pharmaceuticals annual working capital year-on-year change?
Over the past year, AMPH annual working capital has changed by +$96.12 M (+36.38%)
What is Amphastar Pharmaceuticals quarterly working capital?
The current quarterly working capital of AMPH is $360.31 M
What is the all time high quarterly working capital for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly working capital is $386.94 M
What is Amphastar Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, AMPH quarterly working capital has changed by $0.00 (0.00%)